Please login to the form below
sales models
This page shows the latest sales models news and features for those working in and with pharma, biotech and healthcare.
Choices, choices...
And just as different biological species make different choices, then different business models are characterised by the risk and return trade-offs they make. ... This is true not just between companies but also between different business models within
Latest news
-
La La Land? The myth of multichannel excellence
representative-led sales models. ... Worse still, only 11% provide their sales force with an integrated customer database that bridges all channels - meaning omnichannel customer intelligence remains low.
-
Choose or lose
In biology, peaks represent successful species and, in the life science industry, peaks represent successful business models. ... How is this relevant? Well, it implies that hybrid business models will fail and business models that represent clear
-
The Italian Job
The Italian Job. Therapy efficacy and value-based reimbursement models. In my August column in this publication, I spoke about the need for establishing a mechanism that would allow stakeholders to
-
Dive in: gaining leadership in a therapeutic area
Therapeutic area leadership was once defined simply by who had the biggest and best drug for that condition; the level of 'leadership' could usually be measured by sales figures, but times ... sales and its top-selling cancer drugs (Rituxan/MabThera,
-
The lost art of selling
Let's start with the humble sales aid. In my opinion we used to be pretty good at these. ... Lesson one - Sales aids should be created by people who understand how to sell.
More from news
Approximately 4 fully matching, plus 29 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2018
Up to $75m per product in sales milestones. On option exercise Denali and Takeda will share 50:50 development/commercialisation costs and share profits. ... Royalty monetisation, share purchase. 250. Agenus/HealthCare Royalty Partners. Royalties on sales
-
Choosing destiny
To allow for this, firms ranked alternative models in relative, not absolute, terms. ... Build. Low relative risk. Manage. Focus. Table 2: A portfolio comparison of business models.
-
Healthcare business and operating models redefined
They must realise the fundamental impact new business models will have on their organisations. ... These models represent potential strategies and direction that life science companies can take.
-
M&A is now vital to pharma - but it's vital to get it right
deals. Senior leaders will need to ensure agility in their operating models so that they can anticipate and respond to challenges ahead.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Syndicated or dedicated sales force?
Pharmaceutical companies commonly use outsourced sales teams to support their existing promotional efforts. ... Ashfield were the first to introduce syndicated sales teams over 10 years ago.
-
Infographic: Sales outsourcing as a change partner
As a result, the pharma industry is exploring new sales and marketing models, evolving its strategies to meet these modern, multifaceted challenges.Traditionally, contract sales organisations (CSOs) have provided a flexible, ... The participants included
-
Ashfield publishes white paper on sales outsourcing as a change partner
In response, the pharma industry is exploring new sales and marketing models, evolving its core strategies to meet these modern, multifaceted challenges. ... The participants included 14 senior sales and buying professionals from pharmaceutical companies
-
Digital Marketing : The Road to 2020 - How to develop effective and measurable digital strategies that achieve competitive advantage and ROI
In this white paper:. The role of digital in new pharma sales and marketing models.
More from PMHub
Approximately 1 fully matching, plus 3 partially matching documents found.
Featured jobs
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
-
Scientific Director
-
Great salary and bebefits
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Senior Medical Writer
-
Great salary and bebefits
- Project Manager, Medical Communications, London
-
Excellent Salary
- Account Manager – Med Comms – London
-
Salary TBC
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Senior Account Manager / Account Director
-
Great salary and bebefits
-
Senior Medical Writer
-
Great salary and benefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Senior Programme Executive
-
Salary TBC
Subscribe to our email news alerts
- BenevolentAI raises $115m to fund drug development
- Shire rebuffs Takeda bids, as Allergan bows out
- Abeona Therapeutics names CEO
- Zelluna Immunotherapy appoints chief technology officer
- Spirit Health Group offers new market access consultancy service
- Why heading online for scientific meetings can yield greater HCP engagement
PMHub
Ashfield
Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...
Latest intelligence
- Why heading online for scientific meetings can yield greater HCP engagement
- Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Quick links
Infographics
